• FDA issued Modified Risk Tobacco Product orders for 20 ZYN nicotine pouch variants, allowing a lower-risk claim versus cigarettes.
• Decision marks the first MRTP authorizations for nicotine pouches, expanding PMI’s FDA-cleared reduced-risk portfolio in the U.S.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Philip Morris International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260630053034) on June 30, 2026, and is solely responsible for the information contained therein.